Stock · KIMS · Healthcare
KIMS share price target 2026
Support, resistance, the F&O structure and the BazaarBaazi Crack Score for KRISHNA INSTITUTE OF MEDICAL SCIENCES LIMITED, refreshed every end-of-day run. A systematic, data-only read on KRISHNA INSTITUTE OF MEDICAL SCIENCES LIMITED: where it trades versus its 50-day and 200-day lines, the live 52-week range, and momentum, refreshed from the scanner's real price series each run.
The verdict
BazaarBaazi reads KIMS as range-bound with a Crack Score of 49/100 as of 25 Jul 2026.
BazaarBaaziSource & method
The scanner's readScanned · scanned 24 Jul 2026
Where KIMS stands on the 500-name BazaarBaazi setup scanner: technicals, filed fundamentals and money flow read together, refreshed every run.
Scanned and scored this run, but the evidence is incomplete or conflicted. The engine fails closed to NO_TRADE.
Technical axis
100/100Fundamental axis
0/100Money flow
55/100Result pulse · Q4 FY26
40/100Technical evidence
price above 50DMA
price above 150DMA
price above 200DMA
50 > 150 > 200 DMA (clean stack)
ATR contracting (volatility dry-up)
coiling 1-12% under 52w high
holding above 50DMA
above 200DMA
Red flags
above 200DMA (not a confirmed short-side trend)
Relative valuation
P/E (TTM)
129.8P/E vs sector
+2.6%Sector percentile
94PEG
n/aScanner levels from the deterministic engine run of 2026-07-24, not a SEBI-registered recommendation and not investment advice. The fundamental axis reads the official filing: Q4 FY26 result.
Price target: support and resistanceComputed 25 Jul 2026
Support and resistance for KIMS are read inside the latest show; no spot was printed in the most recent editorial note.
Levels are read inside the latest show. The most recent editorial reference is Systematic Read on 21 Jul 2026.
These are structural reference lines, not a SEBI-registered price target. BazaarBaazi is independent media; the levels frame how the desk reads the KIMS chart, refreshed every end-of-day run.
The Crack Score, and how it is built49 / 100 · Range / mixed
The Crack Score is a deterministic 0 to 100 conviction number. Here is exactly what moved it for KIMS, so the figure is a transparent signal rather than a vibe.
Base 50, adjusted by the factors above and clamped to 0 to 100. How the Crack Score works.
The F&O viewHorizon · swing
How the futures and options structure on KIMS reads right now.
The editorial price read on KIMS is neutral. Strike-level option inventory is unavailable, so the page withholds writer, wall and pin claims. Single-stock F&O on KIMS can be thinner than index F&O, so the desk weights price and filed evidence over raw OI. This is not a derivatives trade recommendation.
Why it movedLatest editorial line
The most recent BazaarBaazi read on what is driving KIMS.
Systematic read: a disclosed, data-only model on real 1-year price structure.
Read in Systematic Read on 21 Jul 2026. Why KIMS moved, the living explainer, tracks every move on one URL.
Latest filed resultsQ4 FY26
KRISHNA INSTITUTE OF MEDICAL SCIENCES LIMITED's most recent quarter, parsed straight from the official NSE filing. Every figure links back to its primary source.
Result Pulse
40 / 100Revenue
Rs 1,075 crNet profit
Rs 33 crEPS (quarter)
Rs 1.06| Growth | YoY | QoQ |
|---|---|---|
| Revenue | n/a | +7.7% |
| Net profit | n/a | -36.2% |
| Net margin | +3.1% | |
Figures are the Q4 FY26 result for KRISHNA INSTITUTE OF MEDICAL SCIENCES LIMITED, parsed straight from the official NSE integrated filing and verified to the paisa. The EPS shown is for the quarter, not a trailing-twelve-month figure, so it is not a P/E input.
Earnings history, every filed quarter20 quarters on record
KRISHNA INSTITUTE OF MEDICAL SCIENCES LIMITED's official quarterly revenue, EPS and Result Pulse trail, every quarter the desk holds from the verified filings export, back to 30 Jun 2021. These are quarterly facts, not TTM valuation inputs.
KIMS official result trail
20 quarters
Quarterly figures only: revenue, net profit and EPS are copied from official filings. EPS here is not trailing twelve month EPS and is not used for valuation.
| Quarter | Revenue | EPS | PAT YoY | Pulse | Source |
|---|---|---|---|---|---|
| Q4 FY26ended 31 Mar 2026 / Consolidated, audited | Rs 1,075 cr | Rs 1.06 | n/a | n/a | Filing |
| Q3 FY26ended 31 Dec 2025 / Consolidated, audited | Rs 998 cr | Rs 1.33 | n/a | n/a | Filing |
| Q2 FY26ended 30 Sep 2025 / Consolidated, audited | Rs 961 cr | Rs 1.67 | n/a | 50/100 | Filing |
| Q1 FY26ended 30 Jun 2025 / Consolidated, audited | Rs 872 cr | Rs 1.96 | n/a | n/a | Filing |
| Q4 FY25ended 31 Mar 2025 / Consolidated, audited | Rs 797 cr | Rs 2.54 | n/a | n/a | Filing |
| Q3 FY25ended 31 Dec 2024 / Consolidated, audited | Rs 772 cr | Rs 2.22 | n/a | n/a | Filing |
| Q2 FY25ended 30 Sep 2024 / Consolidated, audited | Rs 777 cr | Rs 2.68 | n/a | n/a | Filing |
| Q1 FY25ended 30 Jun 2024 / Consolidated, audited | Rs 688 cr | Rs 10.82 | n/a | n/a | Filing |
| Q4 FY24ended 31 Mar 2024 / Consolidated, audited | Rs 634 cr | Rs 8.18 | n/a | n/a | Filing |
| Q3 FY24ended 31 Dec 2023 / Consolidated, audited | Rs 606 cr | Rs 8.98 | n/a | n/a | Filing |
| Q2 FY24ended 30 Sep 2023 / Consolidated, audited | Rs 652 cr | Rs 11.50 | n/a | n/a | Filing |
| Q1 FY24ended 30 Jun 2023 / Consolidated, audited | Rs 606 cr | Rs 10.10 | n/a | n/a | Filing |
| Q4 FY23ended 31 Mar 2023 / Consolidated, audited | Rs 576 cr | Rs 11.65 | n/a | n/a | Filing |
| Q3 FY23ended 31 Dec 2022 / Consolidated, audited | Rs 562 cr | Rs 9.49 | n/a | n/a | Filing |
| Q2 FY23ended 30 Sep 2022 / Consolidated, audited | Rs 564 cr | Rs 12.14 | n/a | n/a | Filing |
| Q1 FY23ended 30 Jun 2022 / Consolidated, audited | Rs 496 cr | Rs 8.74 | n/a | n/a | Filing |
| Q4 FY22ended 31 Mar 2022 / Consolidated, audited | Rs 372 cr | Rs 10.08 | n/a | n/a | Filing |
| Q3 FY22ended 31 Dec 2021 / Consolidated, audited | Rs 394 cr | Rs 10.14 | n/a | n/a | Filing |
| Q2 FY22ended 30 Sep 2021 / Consolidated, audited | Rs 412 cr | Rs 10.34 | n/a | n/a | Filing |
| Q1 FY22ended 30 Jun 2021 / Consolidated, audited | Rs 473 cr | Rs 11.48 | n/a | n/a | Filing |
The official financialsFiled to 31 Mar 2026
KRISHNA INSTITUTE OF MEDICAL SCIENCES LIMITED's statements as filed: trailing twelve month P&L, the balance sheet, and the cash engine. Parsed from official XBRL, shown in crore.
Trailing twelve months, on filed quarters
Revenue (TTM)
3,905 crNet profit (TTM)
242 crEBIT (TTM)
534 crProfit before tax (TTM)
331 crNet margin (TTM)
6.2%Finance costs (TTM)
203 crBalance sheet, as filed 2026-03-31
Total assets
7,759 crShareholder equity
2,559 crTotal borrowings
3,244 crCash and equivalents
55.4 crInventory
96.9 crTrade receivables
554 crThe cash engine, latest filed year
Operating cash flow
511 crCapex
1,428 crFree cash flow
-917 crInvesting flow
-1,452 crFinancing flow
940 crAnnual trail, filed year over filed year
| Year | Revenue | Net profit | Equity | Borrowings | CFO |
|---|---|---|---|---|---|
| FY26 | 3,905 cr | 242 cr | 2,559 cr | 3,244 cr | 511 cr |
| FY25 | 3,035 cr | 415 cr | 2,419 cr | 2,557 cr | 582 cr |
| FY24 | 2,498 cr | 336 cr | 2,093 cr | 1,355 cr | 521 cr |
| FY23 | 2,198 cr | 366 cr | 1,938 cr | 678 cr | 432 cr |
| FY22 | 1,651 cr | 344 cr | 1,411 cr | 161 cr | 520 cr |
Every figure is parsed from KRISHNA INSTITUTE OF MEDICAL SCIENCES LIMITED's official NSE XBRL filings by the BazaarBaazi earnings lab and shown in crore rupees. Display data, not a valuation model input.
Management on record20 earnings calls
Every KIMS earnings call BazaarBaazi has indexed, latest 31 May 2026. Read management in its own words, straight from the filed transcript.
KRISHNA INSTITUTE OF MEDICAL SCIENCES LIMITED earnings calls on record
20 calls since 30 Nov 2021
Show 12 older calls
Each entry links to the transcript PDF the company filed with the exchange. Primary sources, in management's own words.
What changed1 disclosure
Every recent official filing from KRISHNA INSTITUTE OF MEDICAL SCIENCES LIMITED, straight from the exchange feed, with the BazaarBaazi Event Heat on the disclosure flow.
KRISHNA INSTITUTE OF MEDICAL SCIENCES LIMITED's most recent official filing is a Earnings dated 31 Mar 2026.
Event Heat
61 / 100KRISHNA INSTITUTE OF MEDICAL SCIENCES LIMITED Q4 FY26 earnings result: mixed
Event Heat is a dated net read of KRISHNA INSTITUTE OF MEDICAL SCIENCES LIMITED's last 180 days of official disclosures, balancing the constructive filings against the ones to watch. It is a signal from what the company has filed, not investment advice. Every line above links to its official exchange filing, and the full market desk is at the disclosures hub.
Key fundamentalsEditorial reference
The anchor data BazaarBaazi references when reading the KIMS chart. Not a substitute for a registered research note.
| Ticker | KIMS |
|---|---|
| Full name | KRISHNA INSTITUTE OF MEDICAL SCIENCES LIMITED |
| Sector | Healthcare |
| Index class | MID CAP |
| ISIN | INE967H01025 |
| Market-cap band | ~24,683 cr (indicative) |
| Last referenced level | Inside latest show |
| Last session move | Not referenced this cycle |
| Editorial line in | Systematic Read on 21 Jul 2026 |
| Aliases tracked | KIMS |
Reference chartLevels in show
The daily frame the desk reads on KIMS.
FAQ11 reader questions · AEO-eligible
The line on KIMS, distilled and schema-marked for AI Overview, Perplexity, and reader search.
What is the KIMS share price target for 2026?
BazaarBaazi does not publish a SEBI-registered price target on KIMS. The desk reads structural support and resistance inside each show against the printed spot; the most recent editorial line is Systematic Read on 21 Jul 2026.
What is BazaarBaazi's Crack Score for KIMS?
The BazaarBaazi Crack Score for KIMS is 49 out of 100 as of 25 Jul 2026, a range / mixed reading. It is a computed conviction number from the signed stance, how consistent the recent verdicts have been, the quality of the printed structure, and how fresh the review is. It is a transparency signal, not investment advice.
What is the F&O view on KIMS?
Strike-level option inventory for KIMS is unavailable, so BazaarBaazi withholds participant, direction and positioning claims. The editorial chart stance is not substituted for an option-chain observation.
What sector is KIMS in and which peers does BazaarBaazi track?
KIMS sits in Healthcare (mid cap), indicative market cap ~24,683 cr (indicative), ISIN INE967H01025. The peers BazaarBaazi reads alongside it are GLAND PHARMA LIMITED, Eris Lifesciences Limited, ACUTAAS CHEMICALS LIMITED. A systematic, data-only read on KRISHNA INSTITUTE OF MEDICAL SCIENCES LIMITED: where it trades versus its 50-day and 200-day lines, the live 52-week range, and momentum, refreshed from the scanner's real price series each run.
How often is the KIMS view updated?
This page is one evergreen URL refreshed in place. The Crack Score and levels re-compute on every BazaarBaazi end-of-day run, and the dated stamp shows the last refresh. The latest signed verdict on KIMS is neutral, published in Systematic Read on 21 Jul 2026.
Is KIMS a qualifying setup on the BazaarBaazi scanner right now?
On the 2026-07-24 run of the 500-name BazaarBaazi setup scanner, KRISHNA INSTITUTE OF MEDICAL SCIENCES LIMITED sits in the Scanned tier with a setup score of 61/100 (technical 100, fundamental 0). The scanner is a deterministic engine over real OHLCV and official filings, refreshed nightly, and it is a signal rather than investment advice.
Where can I read KRISHNA INSTITUTE OF MEDICAL SCIENCES LIMITED's earnings call transcripts?
BazaarBaazi indexes 20 KIMS earnings calls going back to 2021-11-30, latest 2026-05-31. Every entry on this page links straight to the transcript PDF the company filed with the exchange, so you read management in the primary source.
What was KRISHNA INSTITUTE OF MEDICAL SCIENCES LIMITED's Q4 FY26 net profit?
KRISHNA INSTITUTE OF MEDICAL SCIENCES LIMITED reported a net profit of Rs 33 cr for Q4 FY26 (the quarter ended 31 March 2026). The figure is from the company's official NSE filing.
What was KRISHNA INSTITUTE OF MEDICAL SCIENCES LIMITED's Q4 FY26 revenue?
KRISHNA INSTITUTE OF MEDICAL SCIENCES LIMITED reported revenue of Rs 1,075 cr for Q4 FY26. The figure is from the company's official NSE filing.
How does BazaarBaazi rate KRISHNA INSTITUTE OF MEDICAL SCIENCES LIMITED's Q4 FY26 result?
BazaarBaazi gives KRISHNA INSTITUTE OF MEDICAL SCIENCES LIMITED's Q4 FY26 result a Result Pulse of 40 out of 100, with a verdict of Mixed. The Result Pulse is a BazaarBaazi editorial score for the quality of the filed result, not investment advice.
What has Krishna Institute of Medical Sciences Ltd announced recently?
The most recent official filing on record for Krishna Institute of Medical Sciences Ltd is an earnings dated 31 Mar 2026. It is the company's own earnings disclosure to the exchange, and it links to that filing on the BazaarBaazi stock page rather than to any third-party summary.
Related stock views
The names BazaarBaazi reads alongside KIMS, each a living view refreshed every end-of-day run.